143 related articles for article (PubMed ID: 11867193)
1. Is hepatitis B virus subtype testing useful in predicting virological response and resistance to lamivudine?
Buti M; Cotrina M; Valdes A; Jardi R; Rodriguez-Frias F; Esteban R
J Hepatol; 2002 Mar; 36(3):445-6. PubMed ID: 11867193
[No Abstract] [Full Text] [Related]
2. Hepatitis B virus resistance to antivirals: clinical implications and management.
Zoulim F
J Hepatol; 2003; 39 Suppl 1():S133-8. PubMed ID: 14708691
[No Abstract] [Full Text] [Related]
3. [Lamivudine resistance impedes hepatitis B therapy].
Eggers HJ
Fortschr Med; 1997 Apr; 115(12):5. PubMed ID: 9235306
[No Abstract] [Full Text] [Related]
4. Tenofovir disoproxil fumarate exhibits strong antiviral effect in a patient with lamivudine-resistant severe hepatitis B reactivation.
Van Bömmel F; Schernick A; Hopf U; Berg T
Gastroenterology; 2003 Feb; 124(2):586-7. PubMed ID: 12557178
[No Abstract] [Full Text] [Related]
5. Lamivudine resistance in immunocompetent chronic hepatitis B. Incidence and patterns.
Honkoop P; Niesters HG; de Man RA; Osterhaus AD; Schalm SW
J Hepatol; 1997 Jun; 26(6):1393-5. PubMed ID: 9210628
[TBL] [Abstract][Full Text] [Related]
6. Lamivudine for chemotherapy-induced reactivation of HBV: prophylaxis or treatment?
Mancuso A; Pagliaro L
Am J Gastroenterol; 2002 May; 97(5):1268-9. PubMed ID: 12014746
[No Abstract] [Full Text] [Related]
7. Hepatitis B viral genotypes and lamivudine resistance.
Kao JH; Liu CJ; Chen DS
J Hepatol; 2002 Feb; 36(2):303-4. PubMed ID: 11830346
[No Abstract] [Full Text] [Related]
8. Lamivudine resistant occult HBV: implications for public health?
Bowden S; Bartholomeusz A; Locarnini S
J Hepatol; 2003 Apr; 38(4):526-8. PubMed ID: 12663248
[No Abstract] [Full Text] [Related]
9. Adefovir-lamivudine combination therapy and hepatitis B viral kinetics.
Mutimer D
J Hepatol; 2005 Aug; 43(2):200-2. PubMed ID: 15975684
[No Abstract] [Full Text] [Related]
10. Failure of lamivudine therapy for chemotherapy-induced reactivation of hepatitis B.
Cainelli F; Longhi MS; Concia E; Vento S
Am J Gastroenterol; 2001 May; 96(5):1651-2. PubMed ID: 11374725
[No Abstract] [Full Text] [Related]
11. Persistence of YMDD variants after withdrawal of Lamivudine.
van der Eijk AA; Niesters HG; Pas SD; de Man RA
J Hepatol; 2002 Feb; 36(2):304-5. PubMed ID: 11830347
[No Abstract] [Full Text] [Related]
12. Adefovir dipivoxil as a treatment for hepatic failure caused by lamivudine-resistant HBV strains.
Kuwahara R; Kumashiro R; Inoue H; Tanabe R; Tanaka E; Hino T; Ide T; Koga Y; Sata M
Dig Dis Sci; 2004 Feb; 49(2):300-3. PubMed ID: 15104374
[No Abstract] [Full Text] [Related]
13. The effect of lamivudine on the replication of hepatitis B virus in HIV-infected patients depends on the host immune status (CD4 cell count).
Haverkamp M; Smit M; Weersink A; Boucher CA; Hoepelman AI
AIDS; 2003 Jul; 17(10):1572-4. PubMed ID: 12824802
[TBL] [Abstract][Full Text] [Related]
14. Survival of infantile fulminant hepatitis B and treatment with Lamivudine.
Laubscher B; Gehri M; Roulet M; Wirth S; Gerner P
J Pediatr Gastroenterol Nutr; 2005 Apr; 40(4):518-20. PubMed ID: 15795605
[No Abstract] [Full Text] [Related]
15. Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy.
Chayama K; Suzuki Y; Kobayashi M; Kobayashi M; Tsubota A; Hashimoto M; Miyano Y; Koike H; Kobayashi M; Koida I; Arase Y; Saitoh S; Murashima N; Ikeda K; Kumada H
Hepatology; 1998 Jun; 27(6):1711-6. PubMed ID: 9620347
[TBL] [Abstract][Full Text] [Related]
16. Drug-resistant viral hepatitis.
Wright M; Main J; Thomas HC
J Infect; 2000 Jul; 41(1):1-4. PubMed ID: 10942634
[No Abstract] [Full Text] [Related]
17. Selection of multiresistant hepatitis B virus during sequential nucleoside-analogue therapy.
Mutimer D; Pillay D; Cook P; Ratcliffe D; O'Donnell K; Dowling D; Shaw J; Elias E; Cane PA
J Infect Dis; 2000 Feb; 181(2):713-6. PubMed ID: 10669360
[TBL] [Abstract][Full Text] [Related]
18. HBV genotypic resistance to lamivudine in kidney recipients and hemodialyzed patients.
Fontaine H; Thiers V; Chrétien Y; Zylberberg H; Poupon RE; Bréchot C; Legendre C; Kreis H; Pol S
Transplantation; 2000 May; 69(10):2090-4. PubMed ID: 10852602
[TBL] [Abstract][Full Text] [Related]
19. Lamivudine and famciclovir treatment in HIV patients with acute hepatitis B virus infection and hepatitis B reactivation.
Panos GZ; Lampropoulos KM; Angelousi AG; Charatsis GG; Falagas ME
J Clin Gastroenterol; 2007 Feb; 41(2):222-3. PubMed ID: 17245225
[No Abstract] [Full Text] [Related]
20. Tenofovir treatment in patients with lamivudine-resistant hepatitis B mutants strongly affects viral replication.
van Bömmel F; Wünsche T; Schürmann D; Berg T
Hepatology; 2002 Aug; 36(2):507-8. PubMed ID: 12143063
[No Abstract] [Full Text] [Related]
[Next] [New Search]